Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA

详细信息    查看全文

• 作者：Yan Li^a ; ^d ; ¹ ; Qiang Cheng^b ; ¹ ; Qian Jiang^b ; Yuanyu Huang^b ; Hongmei Liu^a ; ^d ; Yuliang Zhao^c ; Weipeng Cao^c ; Guanghui Ma^a ; Fengying Dai^a ; ^{fydai@home.ipe.ac.cn" class="auth_mail} ; Xingjie Liang^c ; ^{liangxj@nanoctr.cn" class="auth_mail} ; Zicai Liang^b ; ^{liangz@pku.edu.cn" class="auth_mail} ; Xin Zhang^a ; ² ; ^{xzhang@home.ipe.ac.cn" class="auth_mail}
• 关键词：siRNA delivery ; Cationic liposomes ; Polycarboxybetaine ; pH-sensitive ; Endosomal/lysosomal escape
• 刊名：Journal of Controlled Release
• 出版年：28 February, 2014
• 年：2014
• 卷：176
• 期：Complete
• 页码：104-114
• 全文大小：1804 K

文摘

Cationic liposome based siRNA delivery system has improved the efficiencies of siRNA. However, cationic liposomes are prone to be rapidly cleared by the reticuloendothelial system (RES). Although modification of cationic liposomes with polyethylene glycol (PEG) could prolong circulation lifetime, PEG significantly inhibits siRNA entrapment efficiency, cellular uptake and endosomal/lysosomal escape process, resulting in low gene silencing efficiency of siRNA. In this study, we report the synthesis of zwitterionic polycarboxybetaine (PCB) based distearoyl phosphoethanolamine-polycarboxybetaine (DSPE-PCB) lipid for cationic liposome modification. The DSPE-PCB₂₀ cationic liposome/siRNA complexes (lipoplexes) show an excellent stability in serum medium. The siRNA encapsulation efficiency of DSPE-PCB₂₀ lipoplexes could reach 92% at N/P ratio of 20/1, but only 73% for DSPE-PEG lipoplexes. The zeta potential of DSPE-PCB₂₀ lipoplexes is 8.19 卤 0.53 mV at pH 7.4, and increases to 24.6 卤 0.87 mV when the pH value is decreased to 4.5, which promotes the endosomal/lysosomal escape of siRNA. The DSPE-PCB₂₀ modification could enhance the silencing efficiency of siRNA by approximately 20% over the DSPE-PEG 2000 lipoplexes at the same N/P ratio in vitro. Furthermore, DSPE-PCB₂₀ lipoplexes could efficiently mediate the down-regulation of Apolipoprotein B (ApoB) mRNA in the liver and consequently decrease the total cholesterol in the serum in vivo, suggesting therapeutic potentials for siRNA delivery in hypercholesterolemia-related diseases.